澳大利亚原住民社区痴呆风险管理和预防计划 (DAMPAA):一种随机对照试验研究协议
Alex Lalovic1, Glennette Dowden2, Lesley Markey2
1Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia alex.lalovic@uwa.edu.au kate.smith@uwa.edu.au.
BMJ open
|September 14, 2024
概括
澳大利亚原住民痴呆症预防和风险管理计划 (DAMPAA) 试验调查了一种文化定制的干预措施,以减少老年原住民痴呆症风险因素. 研究结果将为澳大利亚原住民未来的痴呆症预防策略提供信息.
科学领域:
- 公共卫生 公共卫生
- 老年学是指老年学的学科.
- 土著健康土著健康
背景情况:
- 痴呆症不成比例地影响土著和托雷斯海峡岛民,高达45%的病例与可修改的风险因素有关.
- 需要文化上适当的干预措施来解决老年澳大利亚土著人的认知衰退.
研究的目的:
- 评估澳大利亚原住民痴呆症预防和风险管理计划 (DAMPAA) 的有效性.
- 通过文化定制的计划,减少老年土著人的认知衰退,功能障碍和管理风险因素.
主要方法:
- 一个多站点的随机对照试验,涉及45-90岁的社区居民原住民.
- 参与者被随机分配到一个为期12个月的小组计划 (运动,健康教育,药物评价) 或通常的护理.
- 结果包括认知功能 (KICA-Cog),日常功能 (KICA-ADL) 和生活质量,其次要结果是心血管风险因素,跌倒和死亡率.
主要成果:
- *当研究结果可用时,将填写本部分. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
结论:
- *当研究结果可用时,将填写本部分. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.0K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.8K
相关概念视频
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
